For media inquiries, visit the Office of Media Relations website or call 702-895-3102.
Newsletter Subscription
Want to see how UNLV is covered in national and local media outlets? Subscribe to the Office of Media Relations' "UNLV In The News" newsletter for top headlines. It is emailed to subscribers on weekdays. Submit the form below to subscribe.
Despite supportive community efforts, the Vegas Strong Fund continues to raise funds for the project set to break ground in October.
Native Americans are reclaiming traditions and learning languages their ancestors were beaten for speaking. But after centuries of repression, migration and intermarriage, a debate is raging about who gets to call themselves Indian.
The Kirk Kerkorian School of Medicine at UNLV has received LEED Platinum Certification for the operations and maintenance of its Medical Education Building, the highest tier in the world’s most widely used green building rating system, university officials said in a news release.
A sparsely-populated state known for its world-class casinos and dry desert climate has been a bright spot in the tepid U.S. job market.
Fatal wrong-way crashes are increasing in Nevada, with Clark County accounting for the largest share of those deadly collisions, according to a new analysis from UNLV's Nevada Traffic Safety Research Center.
Among all the stressors identified, intergenerational conflict emerged as one of the most significant.
As summer approaches, Las Vegas casinos and resorts downtown and on the Las Vegas Strip are rolling out staycation deals aimed at locals looking for a getaway without the cost of airfare or long road trips.
Dr. Kelly Tseng a professor in the School Of Life Sciences at the University of Nevada-Las Vegas, discusses how discovering the method in which frogs are able to regenerate eye tissue could lead to finding out how to replicate the process in humans.
The extended-release oral combination of dextromethorphan-bupropion uses a different mechanism of action than antipsychotic medications, which clinicians sometimes prescribe for patients with Alzheimer's disease who also experience agitation. But whether the new medication will be used as a first-line treatment is up for debate.